Teva And Sanofi Data Add Potential Branded Growth Option In IBD [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Teva Pharmaceutical Industries (NYSE:TEVA) and Sanofi reported positive 44 week data from the RELIEVE UCCD study for duvakitug in ulcerative colitis and Crohn's disease. The investigational monoclonal antibody targets TL1A, a protein linked to inflammatory bowel diseases. The long term results support prior phase outcomes on both efficacy and safety measures. For you as an investor, this update sits at the intersection of Teva's established generics business and its efforts to expand in branded and specialty medicines. Inflammatory bowel diseases are a focus area for multiple global drugmakers, and additional treatment options can attract close attention from both clinicians and payers. The RELIEVE UCCD data gives Teva another clinical asset to watch as the company develops its pipeline alongside existing
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Yahoo Finance [Yahoo! Finance]Yahoo! Finance
- Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its 75% One Year Rally? [Yahoo! Finance]Yahoo! Finance
- Is Teva Pharmaceutical Industries (TEVA) A Good Stock To Buy Now? [Yahoo! Finance]Yahoo! Finance
- Does Blackstone's Private Credit Strains And AI Push With Anthropic Reshape The Bull Case For BX? [Yahoo! Finance]Yahoo! Finance
- A Look At Teva Pharmaceutical Industries (TEVA) Valuation After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
TEVA
Earnings
- 1/28/26 - Beat
TEVA
Sec Filings
- 3/17/26 - Form 144
- 3/9/26 - Form 4
- 3/9/26 - Form 4
- TEVA's page on the SEC website